Abstract:Objective: To develop and validate a risk scoring tool to identify those who are at increased risk of chlamydia infection. Methods: We used demographic data, sexual behaviour information and chlamydia positivity results from more than 45 000 individuals who attended Sydney Sexual Health Centre between 1998 and 2009. Participants were randomly allocated to either the development or internal validation data set. Using logistic regression, we created a prediction model and weighted scoring system using the development data set and calculated the odds ratio of chlamydia positivity for participants in successively higher quintiles of score. The internal validation data set was used to evaluate the performance characteristics of the model for five quintiles of risk scores including population attributable risk, sensitivity and specificity. Results: In the prediction model, inconsistent condom use, increased number of sexual partners in last 3 months, genital or anal symptoms and presenting to the clinic for sexually transmitted infections screening or being a contact of a sexually transmitted infection case were consistently associated with increased risk of chlamydia positivity in all groups. High scores (upper quintiles) were significantly associated with increased risk of chlamydia infection. A cut-point score of 20 or higher distinguished a increased risk group with a sensitivity of 95%, 67% and 79% among heterosexual men, women and men who have sex with men (MSM), respectively. Conclusion: The scoring tool may be included as part of a health promotion and/or clinic website to prompt those who are at increased risk of chlamydia infection, which may potentially lead to increased uptake and frequency of testing. INTRODUCTION Chlamydia infection is highly prevalent in young heterosexuals and men who have sex with men (MSM) in Australia, with prevalence estimates of 3e5% in both populations. 2 The majority of chlamydia infections are asymptomatic. Chlamydia is associated with sequelae such as pelvic inflammatory disease and infertility in women and proctitis in men. Also in MSM, chlamydia re-infection of the rectum has been associated with an increased risk of HIV seroconversion. The number of chlamydia notifications continues to increase steadily each year among MSM and young heterosexual men and young women in Australia, 9 as in many other countries. A major public health challenge is therefore to identify individuals at risk of chlamydia and facilitate testing and treatment before the development of chlamydia sequelae and onward transmission to To cite: Wand H, Guy R, Donovan B, et al. Developing and validating a risk scoring tool for chlamydia infection among sexual health clinic attendees in Australia: a simple algorithm to identify those at high risk of chlamydia infection. BMJ Open 2011;1:e000005. doi:10.1136/bmjopen-2010000005 < Prepublication history for this paper is available online. To view these files please visit the journal online (http:// bmjopen.bmj.com). Received 26 September 2010 Accepted 6 January 2011 This final article is available for use under the terms of the Creative Commons Attribution Non-Commercial 2.0 Licence; see http://bmjopen.bmj.com National Centre in HIV Epidemiology and Clinical Research, Sydney, New South Wales, Australia Sydney Sexual Health Centre, Sydney, New South Wales, Australia National Centre in HIV Social Research, University of New South Wales, Sydney, New South Wales, Australia Correspondence to Dr Handan Wand; hwand@nchecr.unsw.edu.au ARTICLE SUMMARY Article focus The authors created a risk assessment tool that allows people to estimate their own chlamydia risk score based on simple non-invasive variables. Key messages The tool described here will potentially provide a simple and cost-effective method of identifying and alerting individuals who would benefit from chlamydia screening. This tool may be included as part of a health promotion and/or clinic website. This tool may potentially lead to increased uptake and frequency of testing. Strengths and Limitations This is the first study to utilize statistical methods to derive a locally-specific assessment tool using 12 years of data from more than 45 000 men and women. The Study population was sexual health clinic attendees who are likely to be at higher risk for Chlamydia infection compared to the general population. Wand H, Guy R, Donovan B, et al. BMJ Open 2011;1:e000005. doi:10.1136/bmjopen-2010-000005 1 Open Access Research group.bmj.com on June 12, 2017 Published by http://bmjopen.bmj.com/ Downloaded from

Increased PCR sensitivity by using paraffin wax as a reaction mix overlay.

chlamydia infection algorithm to identify those at high risk of clinic attendees in Australia : a simple for chlamydia infection among sexual health Developing and validating a risk scoring tool

The osteocyte as a therapeutic target in the treatment of osteoporosis

Clopidogrel(TM): an alternative to acetylsalicylic acid and ticlopidine in antiplatelet therapy?

The international encyclopedia of depression

Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective

Nanogels as Novel Nanocarrier Systems for Efficient Delivery of CNS Therapeutics

Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance

Revolutionizing Neurocare: Biomimetic Nanodelivery via Cell Membranes

Therapeutic Nanomaterials for Neurological Diseases and Cancer Therapy

Novel Biomaterials Based Strategies for Neurodegeneration: Recent Advancements and Future Prospects

Applications of Various Types of Nanomaterials for the Treatment of Neurological Disorders

Lewia avenicola sp. nov. and its Alternaria anamorph from oat grain, with a key to the species of Lewia.

A "lipid myopathy" associated with a hyperkinetic circulatory response to exercise.

Nano-drug delivery and neuroprotection in spinal cord injury

Revolutionizing Stroke Care: Nanotechnology-Based Brain Delivery as a Novel Paradigm for Treatment and Diagnosis

Nanocarriers As a Powerful Vehicle to Overcome Blood-Brain Barrier in Treating Neurodegenerative Diseases: Focus on Recent Advances

Recent advances in nanotechnology and its application for neuro-disease: a review

Navigating the neurological frontier: Macromolecular marvels in overcoming blood-brain barrier challenges for advanced drug delivery

Nanoparticle‐Based Therapeutics for Brain Injury

Disaster Care: National Disaster Medical System